Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

NCT05671991 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT05671991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05671991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
Lead sponsor
Yale University
Phase
Phase 4
Overall status
Active, not recruiting
Start date
March 1, 2023
Completion date
December 31, 2026
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease on dialysis